MX346471B - Proceso de preparacion de anagrelida y analogos de esta. - Google Patents

Proceso de preparacion de anagrelida y analogos de esta.

Info

Publication number
MX346471B
MX346471B MX2013004410A MX2013004410A MX346471B MX 346471 B MX346471 B MX 346471B MX 2013004410 A MX2013004410 A MX 2013004410A MX 2013004410 A MX2013004410 A MX 2013004410A MX 346471 B MX346471 B MX 346471B
Authority
MX
Mexico
Prior art keywords
anagrelide
analogues
preparation
producing
certain analogues
Prior art date
Application number
MX2013004410A
Other languages
English (en)
Other versions
MX2013004410A (es
Inventor
Mcgee Paul
Original Assignee
Shire Llc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Shire Llc filed Critical Shire Llc
Publication of MX2013004410A publication Critical patent/MX2013004410A/es
Publication of MX346471B publication Critical patent/MX346471B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C205/00—Compounds containing nitro groups bound to a carbon skeleton
    • C07C205/13—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups
    • C07C205/20—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups having nitro groups and hydroxy groups bound to carbon atoms of six-membered aromatic rings
    • C07C205/21—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups having nitro groups and hydroxy groups bound to carbon atoms of six-membered aromatic rings having nitro groups and hydroxy groups bound to carbon atoms of the same non-condensed six-membered aromatic ring
    • C07C205/22—Compounds containing nitro groups bound to a carbon skeleton the carbon skeleton being further substituted by hydroxy groups having nitro groups and hydroxy groups bound to carbon atoms of six-membered aromatic rings having nitro groups and hydroxy groups bound to carbon atoms of the same non-condensed six-membered aromatic ring having one nitro groups bound to the ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B43/00—Formation or introduction of functional groups containing nitrogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C201/00—Preparation of esters of nitric or nitrous acid or of compounds containing nitro or nitroso groups bound to a carbon skeleton
    • C07C201/06—Preparation of nitro compounds
    • C07C201/08—Preparation of nitro compounds by substitution of hydrogen atoms by nitro groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/04—Formation of amino groups in compounds containing carboxyl groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/14—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof
    • C07C227/18—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton from compounds containing already amino and carboxyl groups or derivatives thereof by reactions involving amino or carboxyl groups, e.g. hydrolysis of esters or amides, by formation of halides, salts or esters
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/10—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings
    • C07C229/14—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings to carbon atoms of carbon skeletons containing rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

La presente invención se refiere a procesos novedosos para producir anagrelida, 6,7-dicloro-1,5-dihidroimidazo [2,1-b] quinazolin 2 (3H)-ona o determinados análogos de estos. El proceso de la invención también proporciona procesos mejorados para producir intermedios clave necesarios para la síntesis de anagrelida o determinados análogos de esta.
MX2013004410A 2010-10-21 2011-10-21 Proceso de preparacion de anagrelida y analogos de esta. MX346471B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB201017783A GB201017783D0 (en) 2010-10-21 2010-10-21 Process for the preparation of anagrelide and analogues thereof
PCT/GB2011/052053 WO2012052781A1 (en) 2010-10-21 2011-10-21 Process for the preparation of anagrelide and analogues thereof

Publications (2)

Publication Number Publication Date
MX2013004410A MX2013004410A (es) 2013-05-22
MX346471B true MX346471B (es) 2017-03-22

Family

ID=43334164

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2013004410A MX346471B (es) 2010-10-21 2011-10-21 Proceso de preparacion de anagrelida y analogos de esta.

Country Status (16)

Country Link
US (1) US9067944B2 (es)
EP (1) EP2630148B1 (es)
JP (3) JP2013541556A (es)
KR (2) KR102026043B1 (es)
CN (1) CN103180323B (es)
AP (1) AP3540A (es)
AU (1) AU2011319706B2 (es)
BR (1) BR112013009668A2 (es)
CA (1) CA2815017C (es)
CO (1) CO6731071A2 (es)
ES (1) ES2844100T3 (es)
GB (1) GB201017783D0 (es)
IL (1) IL225721A0 (es)
MX (1) MX346471B (es)
WO (1) WO2012052781A1 (es)
ZA (1) ZA201302701B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201017783D0 (en) * 2010-10-21 2010-12-01 Shire Llc Process for the preparation of anagrelide and analogues thereof
CN103333078B (zh) * 2013-06-14 2016-01-20 苏州汇和药业有限公司 一种阿那格雷关键中间体、类似物或其盐的合成方法
WO2024102605A1 (en) * 2022-11-07 2024-05-16 Merck Sharp & Dohme Llc Conjugation of saccharide antigens using acetoxyborohydrides

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3932407A (en) 1973-11-19 1976-01-13 Bristol-Myers Company Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones
USRE31617E (en) 1972-02-04 1984-06-26 Bristol-Myers Company Optionally substituted 1,2,3,5-tetrahydroimidezo(2,1-b)-quinazolin-2-ones and 6(H)-1,2,3,4-tetrahydropyimido(2,1-b)quinazolin-2-ones
US4146718A (en) 1978-04-10 1979-03-27 Bristol-Myers Company Alkyl 5,6-dichloro-3,4-dihydro-2(1h)-iminoquinazoline-3-acetate hydrohalides
US4208521A (en) 1978-07-31 1980-06-17 Bristol-Myers Company Process for the preparation of imidazo[2,1-b]quinazolinones
US4357330A (en) 1981-07-30 1982-11-02 Bristol-Myers Company Pharmaceutical compositions
DE3426956A1 (de) 1984-07-21 1986-01-30 Klöckner-Humboldt-Deutz AG, 5000 Köln Schachtofen zum brennen von koernigen und/oder stueckigen materialien
CA2171073A1 (en) 1995-12-04 1997-06-05 Philip C. Lang Process for the preparation of ethyl-n-(2,3 dichloro-6- nitrobenzyl) glycine
US6388073B1 (en) 2000-07-26 2002-05-14 Shire Us Inc. Method for the manufacture of anagrelide
JP2002308840A (ja) * 2001-04-13 2002-10-23 Kanegafuchi Chem Ind Co Ltd ３−アリール−３−イミノプロピオン酸エステルの立体選択的還元方法
RU2005110062A (ru) * 2002-10-07 2006-01-10 Артезиан Терапьютикс, Инк. (US) Дигидропиридиновые соединения, обладающие одновременной способностью к блокированию кальциевых каналов l-типа и к ингибированию активности фосфодиэстеразы типа 3
US20070060748A1 (en) * 2002-11-27 2007-03-15 Hamilton Gregory S Compounds with mixed pde-inhibitory and beta-adrenergic antagonist or partial agonist activity for treatment of heart failure
US7700608B2 (en) * 2004-08-04 2010-04-20 Shire Holdings Ag Quinazoline derivatives and their use in the treatment of thrombocythemia
GB0623750D0 (en) 2006-11-28 2007-01-10 Shire Llc Substituted quinazolines
GB0808944D0 (en) * 2008-05-16 2008-06-25 Shire Llc Substituted quinazolines
GB0808947D0 (en) * 2008-05-16 2008-06-25 Shire Llc Substituted quinazolines
GB0822970D0 (en) * 2008-12-17 2009-01-21 Shire Llc Process for the preparation of anagrelide and analogues
GB201017783D0 (en) * 2010-10-21 2010-12-01 Shire Llc Process for the preparation of anagrelide and analogues thereof

Also Published As

Publication number Publication date
JP2017008073A (ja) 2017-01-12
MX2013004410A (es) 2013-05-22
CN103180323B (zh) 2016-08-10
CA2815017A1 (en) 2012-04-26
ES2844100T3 (es) 2021-07-21
KR20130140695A (ko) 2013-12-24
CO6731071A2 (es) 2013-08-15
KR101907706B1 (ko) 2018-10-12
AU2011319706B2 (en) 2015-09-24
ZA201302701B (en) 2014-06-25
EP2630148A1 (en) 2013-08-28
WO2012052781A1 (en) 2012-04-26
CA2815017C (en) 2019-04-30
CN103180323A (zh) 2013-06-26
JP2019151666A (ja) 2019-09-12
KR20180110238A (ko) 2018-10-08
EP2630148B1 (en) 2020-11-25
KR102026043B1 (ko) 2019-11-26
BR112013009668A2 (pt) 2016-07-19
GB201017783D0 (en) 2010-12-01
JP2013541556A (ja) 2013-11-14
AU2011319706A1 (en) 2013-05-02
US20130211083A1 (en) 2013-08-15
IL225721A0 (en) 2013-06-27
AP3540A (en) 2016-01-13
AP2013006873A0 (en) 2013-05-31
US9067944B2 (en) 2015-06-30

Similar Documents

Publication Publication Date Title
MY145604A (en) Process for the preparation of chiral 8-(3-aminopiperidine-1-yl)-xanthines
MX2009011255A (es) Proceso para preparar capecitabina.
WO2012107778A3 (en) Mutant pores
TW200800968A (en) Sulfoximine-substituted pyrimidines, processes for production thereof and use thereof as drugs
MX370814B (es) Pirazolo[3,4-d]pirimidinas sustituidas y usos de las mismas.
MA20150025A1 (fr) Mousse minérale isolante
MX2010002836A (es) Bortezomib y proceso para la produccion del mismo.
MX2009007422A (es) Proceso mejorado para la preparacion de fosfolipidos oxidados.
MX2011009369A (es) 2-mercaptoquinolin-3-carboxamidas sustituidas como moduladores de kcnq2/3.
WO2011019986A3 (en) Processes for preparing pemetrexed
WO2010028122A8 (en) Process for making bivalirudin
MX2011008825A (es) 3-aminoisoxazolopiridinas sustituidas como moduladores de kcnq2/3.
TW200728310A (en) Process for the preparation of ferri-succinylcasein
MY155330A (en) Methods for salt production
IN2012DN01342A (es)
MX344858B (es) Nuevo procedimiento para la síntesis de rifaximina y una nueva forma pseudocristalina de rifaximina obtenida con el mismo.
MX2010004546A (es) Nuevos intermedios de pregabalina y procedimiento para prepararlos y para preparar pregabalina.
MX350003B (es) Procedimiento para la fabricación de derivados de dibenzoilmetano.
TW200734326A (en) Crystalline forms of dolasetron base and processes for preparation thereof
EP2137100A4 (en) HIGH SHEAR PROCESS OF CHLORAL PRODUCTION
MX2011008662A (es) 2-mercapto-3-aminopiridinas sustituidas como moduladores de kcnq2/3.
MX2011009338A (es) 3-amino-2-mercaptoquinolinas sustituidas como moduladores de kcnq2/3.
MX2013004410A (es) Proceso de preparacion de anagrelida y analogos de esta.
NZ593814A (en) Process for the preparation of anagrelide and analogues
MY146610A (en) Process of producing bleach boosters

Legal Events

Date Code Title Description
FG Grant or registration